Skip to main content

Investigation of difference between chronological and vascular age in persons with Multiple Sclerosis.

Multiple sclerosis (MS) is traditionally viewed as a disease of younger adults, yet its prevalence in older individuals is increasingly recognized. Despite the availability of more than 20 disease-modifying therapies (DMTs), pivotal trials have largely focused on patients under 55, leaving treatment effectiveness in older populations less understood. Co-authored by a ParadigMS expert, Jelena Drulovic, this article explores the impact of cardiovascular comorbidities in MS, utilizing the innovative concept of vascular age (VA) to assess atherosclerotic burden beyond chronological age. Integrating VA into clinical evaluation could enhance risk stratification and inform tailored treatment strategies for aging persons with MS.

Authors: Gorica D. Maric 1☯, Tatjana D. Pekmezovic 1☯, Olivera S. Tamas 2,3, Nikola D.Veselinovic 2,3, Maja S. Budimkic 2,3, Aleksa L. Jovanovic 1, Sarlota K. Mesaros 2,3, Jelena S. Drulovic 2,3*.

a. Faculty of Medicine, Institute of Epidemiology, University of Belgrade, Belgrade, Serbia, b. Faculty of Medicine, University of Belgrade, Belgrade, Serbia, 3.Clinic of Neurology, University Clinical Center of Serbia, Belgrade, Serbia

☯ – These authors contributed equally to this work

*drulovicjelena@gmail.com

To determine vascular age (VA) in a cohort of persons with multiple sclerosis (PwMS) in Belgrade, Serbia, and to assess the difference between chronological age (CA) and VA, in this population.

A case-control study was conducted at the Clinic of Neurology, University Clinical Center of Serbia in Belgrade. Study participants (n = 274) were recruited during regular outpatient visits. Demographic and clinical characteristics including the presence of CVD comorbidities of PwMS were collected. Data were obtained using a questionnaire, designed and adapted for the study purposes. Additionally, fasting blood samples were collected from all participants, in order to determine their lipid profile. VA was calculated based on the patient’s sex, age, smoking status, total serum cholesterol level and systolic blood pressure (SBP) value. Afterwards, the study sample was divided into five groups with the different levels of the atherosclerotic burden, as follows: 1) PwMS without any CVD comorbidity; 2) PwMS with hyperlipidemia (HLP); 3) PwMS with HLP and hypertension (HTA); 4) PwMS with HLP, HTA and type 2 diabetes, and 5) PwMS with coronary artery disease (CAD). In the statistical analysis, for the determination of factors that are independently associated with the discrepancy between CA and VA in persons with MS, hierarchical regression analysis was performed.

The mean values of CA and VA were statistically significantly different among the groups (p<0.001). Additionally, a significant difference was also detected between CA and VA (p<0.001). The highest VA (66.4±15.8 years) and the difference between CA and VA (6.5 ±7.3 years) were registered only in the group comprising PwMS, HPL, HTA and type 2 diabetes. Results of the hierarchical linear regression analysis showed that the Expanded Disability Status Scale (EDSS) score, Body mass index (BMI), physical activity and the presence of type 2 diabetes, explained a total of 24% of the variations in the difference
between CA and VA, in our cohort of MS patients.

Our study showed significant difference between CA and VA in PwMS and additionally, increasing VA with atherosclerotic burden. Additionally, it has been demonstrated that crucial factors which led to the occurrence of these differences were BMI, physical activity, EDSS and the presence of type 2 diabetes.

The Article can be found on Plos Journal website.




Media

Details

  • Directors

    ParadigMS
  • Author(s)

    Gorica D. Maric, Tatjana D. Pekmezovic, Olivera S. Tamas, Nikola D. Veselinovic, Maja S. Budimkic, Aleksa L. Jovanovic, Sarlota K. Mesaros, Jelena S. Drulovic 
  • Country

    Serbia
  • Release Date

    November 20, 2024
  • Views

We value your opinion.

Selected Value: 1
Give a score from 1 (= not at all likely) to 10 (extremely likely)
Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.
If you have submitted a question above, leave your email so we can get back to you.


FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.